Last updated on May 2019

Moderate to Severe Eczema


Brief description of study

The objective of this study is to investigate if the study medication is effective in reducing eczema symptoms for those with moderate to severe eczema. This is a 65-week study with up to 17 office visits.

 

Clinical Study Identifier: TX220315

Find a site near you

Start Over

ActivMed Practices & Research, Inc. NH

110 Corporate Drive Suite 2 Portsmouth, NH United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.